Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
BIONDOLILLO v. ROCHE HOLDING AG et al
Case Number:
3:17-cv-04056
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
April 03, 2019
Roche Evades Cancer Study Stock-Drop Suit For Second Time
Swiss pharmaceutical company Roche Holding AG escaped, for the second time, a proposed class action accusing it and four executives of misleading investors about the results of a breast cancer study after a New Jersey federal judge dismissed the suit Wednesday.
-
September 25, 2018
Roche Escapes Stock-Drop Suit Over Cancer Drug Results
Roche Holding AG has knocked down a putative securities class action after a New Jersey federal judge concluded that the pharmaceutical giant and its executives did not make false or misleading statements about the results of a breast cancer treatment study.
-
June 07, 2017
Roche Faces Stock Drop Suit Over Cancer Drug Results
Roche was hit with a potential shareholder class action in New Jersey federal court on Tuesday, alleging that the drugmaker misrepresented to investors the effectiveness of a breast cancer treatment under development.